Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly.
Greater Philadelphia’s life sciences ecosystem is starting to move as one. Breakthroughs are moving closer to patients, local research is finding bigger partners beyond and within the region, and the companies behind it all are growing to match, an ecosytem where science, partnerships, and talent are starting to reinforce one another.
With a remarkable run of clinical wins—from AstraZeneca’s twin Phase III lung cancer victories to Merck and Moderna’s personalized melanoma vaccine reaching its Phase 3 endpoints—while Philadelphia’s Tolerance Bio Licenses Clinical-Stage Long-Acting Interleukin-7 Therapy.
The region’s research institutions are reaching outward, too, with Temple and Penn connecting homegrown innovation to international partners and national-scale initiatives. The region’s talent is following the momentum too with veteran leaders stepping into new roles and employers from Southern New Jersey to Philadelphia to Delaware continuing to hire both science and non-science functions.
Financial
Tracking the capital moving through Greater Philadelphia— funding rounds, M&A activity, and investment trends shaping Philadelphia, Southern New Jersey, and Delaware’s life sciences companies.
Universal Health Services, Inc. Completes Acquisition of Talkspace, Inc.
King of Prussia-based UHS completed its $835 million acquisition of Talkspace, closing a deal first announced in March 2026, giving the behavioral health giant its first virtual therapy platform alongside more than 380 inpatient psychiatric facilities. Talkspace brings roughly 6,000 affiliated providers and access for more than 200 million people through insurance and employer partnerships. Read More >
Venture Fellows Program: A 12-Month Fellowship in Early-Stage Life Sciences Investing
Hosted by the Science Center in Philadelphia, PA, the Venture Fellows Program starting September 8, 2026. A launchpad for the next generation of life sciences venture capital talent, fellows evaluate real deals, support founders, and build the analytical rigor of an investor through investment memos, market research, and an Emerging Fund Thesis on early-stage life-science, MedTech, and health tech deals. Read More >
Meduloc Closes $4 Million Series B Financing Led by GenHenn Capital
West Chester-based Meduloc closed a $4 million Series B led by GenHenn Capital to fund the commercial launch of its FDA-cleared fracture fixation platform, clearing the way for a controlled alpha launch with select orthopedic surgeons starting this month, with the CEO crediting regional and state strong backing. Read More >
People
Who we’re buzzing about this week — the leadership moves, board appointments, and rising names shaping the region’s life sciences community.
Orchestra Life Sciences Appoints Charles Conroy as Chief Operating Officer
Orchestra Life Sciences appoints Charles Conroy, RPh, MBA, as Chief Operating Officer, bringing 25+ years of executive leadership across radiopharmaceutical, biotech, and pharmaceutical sectors. Conroy to focus on technical strategy, capital investment, and commercialization, helping Orchestra’s as it continues to expand its global team and capabilities. Read More >
Ephicacy Names Dr. Shekhar Thumake as Head of AI to Advance AI-Enabled Clinical Data Operations
Ephicacy named Dr. Shekhar Thumake as Head of AI, a newly created role reflecting the biometrics CRO’s increased focus on AI within its clinical data operations. Thumake joins from Axtria, where he built production AI tools including an LLM-powered patient screening tool for clinical trials. He began his career as a physician before moving into clinical data management. Read More >
NIIMBL Welcomes Dr. Paul Collins to Lead Process Intensification Program
NIIMBL welcomed Dr. Paul Collins as a Senior Fellow to lead its Process Intensification Program, bringing 30+ years of experience from Merck and Eli Lilly.In the role, Collins will lead the PI Program’s five workstreams, bringing together stakeholders to invent, design, demonstrate, and commercialize biopharmaceutical manufacturing approches. Read More >
Workforce
The hiring activity, team expansions, and talent trends driving growth across Philadelphia, New Jersey, and Delaware life sciences and biotech employers.
How Agilent University Supports Workforce Development
Agilent University delivers hands-on training in troubleshooting, maintenance, sample prep, and software operations across different lab techquies, building job-ready skills scientists can put to work immediately. With facilities across 21 U.S. cities including Wilmington, DE, Agilent trains at 50+ global locations in 15 languages, with formats ranging from on-site at your own facility to live virtual sessions or fully self-paced online learning via ePass. Read More >
American Water Charitable Foundation Awards $75,000 in Workforce Readiness and STEM Education Grants Across New Jersey
Building tomorrow’s STEM workforce starts with giving students meaningful opportunities to explore science today. The American Water Charitable Foundation is investing in that future with $75,000 in grants to four New Jersey nonprofits, including two STEM Education grants, with Students 2 Science receiving $25,000 to support immersive, hands-on STEM lab programs connecting students with real-world science and technology careers. Read More >
Who’s hiring?!
Top Employer
A leading provider of innovative, high-quality injectable solutions, West Pharmaceutical Services is a global leader in designing and manufacturing packaging and delivery systems for injectable medicines, partnering with top pharmaceutical and biotech companies to improve patient health. With 10,000 team members across 50 sites worldwide, West helps deliver billions of components and devices each year, backed by a purpose-led culture and programs like an Employee Stock Purchase Plan, Tuition Reimbursement, and a Scholarship Program.
With U.S. manufacturing sites in Jersey Shore, Upper Darby, and Williamsport, and its global headquarters based in Exton, Pennsylvania, West Pharmaceutical Services calls the Greater Philadelphia region home — anchoring a major piece of the area’s life sciences manufacturing base.
They are currently hiring across 30+ roles in the Greater Philadelphia region. Apply Now >
Other employers and available roles we’re paying attention to this week:
- Pharmaron (Exton, PA) is hiring an IT Lab Systems Specialist | Apply Now >
- Insmed ( Bridgewater, NJ) is hiring a Director, Commercial Analytics | Apply Now >
- AstraZeneca (Wilmington, DE) is hiring a Director, Medical Training | Apply Now >
- Medtronic (Multiple Locations- PA, DE, NJ) is hiring a Clinical Specialist, Cardiac Rhythm Management (CRM) | Apply Now >
- Amgen (Multiple Locations- PA & South Jersey) is hiring a Medical Science Liaison, Uncontrolled Gout – Rare Disease | Apply Now >
Clinical + Commercial
The latest clinical trial progress, regulatory milestones, and commercial launches from companies advancing science from the lab to the market across Greater Philadelphia.
AstraZeneca Posts Twin Phase III Wins in Lung Cancer: Tagrisso-Orpathys Combo and Enhertu Both Hit Primary Endpoints
AstraZeneca delivered positive Phase III results for two different lung cancer drugs — Enhertu pushing into first-line HER2-mutant disease, Tagrisso-savolitinib defending against a common resistance pathway. One expands the frontier, the other holds the line — AstraZeneca’s oncology portfolio advancing on both fronts. Read More >
Merck and Moderna’s Personalized Melanoma Vaccine Hits Its Marks in Phase 3, demonstrates significant reduction in melanoma recurrence
Merck and Moderna announced that the Phase 3 INTerpath-001 trial of Intismeran Autogene plus KEYTRUDA® met endpoints of recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) in patients with completely resected Stage IIB-IV melanoma — the first and only combination regimen to show this benefit in the adjuvant melanoma setting. Read More >
Philadelphia’s Tolerance Bio Licenses Clinical-Stage IL-7 Therapy to Advance Thymic Function Research
Philadelphia-based Tolerance Bio has licensed efineptakin alfa, a clinical-stage IL-7 fusion protein already evaluated in over 800 subjects, from Rockville, MD-based NeoImmuneTech in a deal worth up to $260 million in milestones plus equity and royalties. The company plans to move the therapy into Phase 2 trials targeting thymic function enhancement, with HIV immunological non-response among the first indications studied, a fast pivot into clinical-stage development. Read More >
Ecosystem
The partnerships, programs, and policy moves building Greater Philadelphia’s life sciences infrastructure — and the organizations driving it forward.
Temple’s iNest Sparks International Partnership to Advance Diabetes Care
Temple partnered with U.K.-based Aide Health to launch My Health Aide, an AI-powered platform helping patients manage type 2 diabetes , the company’s first U.S. program, born out of Temple’s Innovation Nest incubator. Funded by an Independence Blue Cross grant, it launches at two Temple Health practices this year. Read More >
Penn researchers join ARPA-H initiative to develop next-gen fetal monitoring device
Penn Medicine joined a nine-institution partnership building OMEGA, a wearable system that measures fetal oxygen levels in real time during labor, a collaboration led by Carnegie Mellon, with Children’s Hospital of Philadelphia co-leading the effort. Backed by up to $39.3 million from ARPA-H, the project brings together Greater Philadelphia’s research and clinical institutions to solve a problem clinicians have faced for decades. Read More >
Other [Good] Reads
Editor’s picks from across the web — the stories, videos, and podcasts shaping the conversation in PHL biotech and life sciences this week.
Conner Strong & Buckelew’s Take on Closing a Coverage Gap in Gene and Cell Therapy
Conner Strong & Buckelew built Product Shortage Plus, an exclusive endorsement designed to protect cell and gene therapy clients from claims tied to product shortages, supply chain disruptions, and unforeseen losses. Hear directly from Senior Partner Andrew Wagner and Vice President Bradley Watts on why they built it and the persistence it took to find insurers willing to back it. Watch Now > | Read More >
On the Calendar
A few of the upcoming events, conferences, and networking opportunities across Greater Philadelphia’s life sciences ecosystem that you don’t want to miss.
Startup Symposium 2026
Wednesday, August 26 • 8 AM – 6 PM EDT • Philadelphia, PA
Hosted by The Project Medtech | Register Now >
Small Business B(AI)sics Training
Wednesday, August 26 • 12 – 1 PM EDT • Wilmington, DE
Hosted by Delaware State Chamber of Commerce | Register Now >
17th Advancing Women’s Leadership in Pharma & Healthcare Conference
Thursday–Friday, August 27–28 • 8 AM -5 PM • Philadelphia, PA
Hosted by Dynamic Global Events | Register Now >
Did we miss something!? Drop us a line →
Stay connected to BioHealth Capital Region life sciences.
🔍 Explore companies → · 💼 Browse jobs → · 📅 See events → · 📰 Read more →
Get the BioHealth Capital Region Roundup every Friday.
The week’s most important life sciences news from BioHealth Capital Region— delivered to your inbox.
